Home » News » September 2020

September, 2020

StartupAus Continues R&D Tax Incentive Advocacy Ahead of Delayed Federal Budget

September 28th, 2020

The federal budget, traditionally in May each year was deferred by the government until 6 October 2020 due to COVID. In comments to Smartcompany.com.au, this week, StartupAus chief Alex McCauley has continued his strong advocacy for the R&D Tax Incentive. Key highlights of Alex’s position include: This year’s budget can be somewhat be considered as two budgets together, in a seven month period; the R&D Tax Incentive is the “number one priority” for this year’s budget; whatever the merits were of amending the […]

Read More

Opposition Critical of Government Innovation Policy as Australia Emerges from COVID-19

May 11th, 2020

An article in The Australian by long time Labor Industry Spokesman Kim Carr this week has been critical of the Australian Government’s R&D Tax Policy, and has linked this to decline in Australian manufacturing and supply chain weakness. Highlights form Carr’s article include the following: The government reintroduced the R&D Tax reform bill in December 2019, despite: A senate economics inquiry concluding that a previous iteration of the bill should be withdrawn due to concerns over complexity, particularly the controversial […]

Read More

STA Lobbying for Australia to Have Greater “Sovereign Capability” in Manufacturing, Underpinned by Strong R&D

April 27th, 2020

In the wake of the COVID-19 situation, there has been numerous parties lobbying that: Not only should the R&D Tax reforms proposed to apply for FY20 be abandoned; but The government should also implement measures to enhance incentives for business investment in R&D. InnovationAus has reported that Science & Technology Australia (STA) has proposed: If the government’s proposed reduction to the R&D Tax Incentive were implemented, that any savings be directed to a research translation fund to help Australia build greater […]

Read More

R&D Tax Incentive Advocate CSL Rapidly Adapts R&D Effort to focus on COVID-19

April 14th, 2020

The Australian newspaper digested the ASX announcement of CSL late last week and detailed how the company, which recently has overtaken CBA as the largest cap stock on the ASX, has rapidly adapted its R&D Effort in response to the COVID-19 situation. The article reports: The health challenges presented by COVID-19 have led to delays in the ability to conduct clinical trials and to progress candidates within the company’s existing pipeline; CSL remains on track to invest 10% of its […]

Read More

Categories

Archives